Literature DB >> 15745493

Correlation between tumor extent in radical prostatectomies and preoperative PSA, histological grade, surgical margins, and extraprostatic extension: application of a new practical method for tumor extent evaluation.

Athanase Billis1, Luís A Magna, Ubirajara Ferreira.   

Abstract

PURPOSE: To evaluate a new method designed for estimating the tumor extent in radical prostatectomy specimens. The tumor extent was correlated to preoperative PSA and to several pathologic findings in the surgical specimens as well.
MATERIALS AND METHODS: Tumor extent was estimated in 118 consecutive radical prostatectomies through a simple point-count method. Drawn on a sheet of paper, each quadrant of the whole mount sections contained 8 equidistant points. During the microscopic slides examination, the tumor area was drawn over the correspondent quadrant of the paper sheet. According to the extent, tumors were classified in 5 groups: 1) very limited: </= 10 positive points; 2) limited: 11-19 positive points; 3) moderately extensive: 20-35 positive points; 4) extensive: 36-39 positive points; 5) very extensive: 70 positive points. This classification was based on a previous analysis of tumor extent in 109 radical prostatectomies. The distribution was quite normal up to 69 positive points, but asymmetric above that number, including cases exceeding far above that value. We considered the quartiles of the normal distribution up to 69 positive points (groups 1 to 4), and above that value a fifth group was considered.
RESULTS: There was a statistically significant and direct correlation between the tumor extent and all variables studied: preoperative PSA (p = 0.03), Gleason score (p < 0.0001), primary grade in high-grade tumors (p < 0.01), surgical margins (p < 0.0001), extraprostatic extension (pT3a) (p < 0.0001), and seminal vesicle invasion (pT3b) (p = 0.01).
CONCLUSIONS: The method, which is simple and well correlated to other prognostic factors, is accessible to those pathologists working in routine pathology laboratories. Whether this method will be used by other urology centers is yet to be seen.

Entities:  

Year:  2003        PMID: 15745493

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  11 in total

1.  A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer.

Authors:  Claire Murphy; Lawrence True; Funda Vakar-Lopez; Jing Xia; Roman Gulati; Bruce Montgomery; Maria Tretiakova
Journal:  Prostate       Date:  2016-06-08       Impact factor: 4.104

2.  In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.

Authors:  Yujiro Ito; Emily A Vertosick; Daniel D Sjoberg; Andrew J Vickers; Hikmat A Al-Ahmadie; Ying-Bei Chen; Anuradha Gopalan; Sahussapont J Sirintrapun; Satish K Tickoo; James A Eastham; Peter T Scardino; Victor E Reuter; Samson W Fine
Journal:  Am J Surg Pathol       Date:  2019-08       Impact factor: 6.394

3.  Are 10-, 10-12-, or > 12-mm prostate biopsy core quality control cutoffs reasonable?

Authors:  Brunno C F Sanches; Ana Luiza Lalli; Wilmar Azal Neto; Athanase Billis; Leonardo Oliveira Reis
Journal:  World J Urol       Date:  2018-03-01       Impact factor: 4.226

4.  Should pathologists continue to use the current pT2 substaging system for reporting of radical prostatectomy specimens?

Authors:  Athanase Billis; Luciana L Meirelles; Leandro L L Freitas; Luis A Magna; Leonardo O Reis; Ubirajara Ferreira
Journal:  Int Urol Nephrol       Date:  2011-02-20       Impact factor: 2.370

5.  Tumor extent in radical prostatectomy specimens: is it an independent prognostic factor for biochemical (PSA) progression following surgery?

Authors:  Athanase Billis; Luciana Meirelles; Leandro L Freitas; Luis A Magna; Ubirajara Ferreira; Leonardo O Reis
Journal:  Int Urol Nephrol       Date:  2010-08-10       Impact factor: 2.370

6.  The value of the 2005 International Society of Urological Pathology (ISUP) modified Gleason grading system as a predictor of biochemical recurrence after radical prostatectomy.

Authors:  Athanase Billis; Maisa M Q Quintal; Luciana Meirelles; Leandro L L Freitas; Larissa B E Costa; João F L Bonfitto; Betina L Diniz; Paola H Poletto; Luís A Magna; Ubirajara Ferreira
Journal:  Int Urol Nephrol       Date:  2013-10-06       Impact factor: 2.370

7.  The significance of microscopic bladder neck invasion in radical prostatectomies: pT4 disease?

Authors:  Thais Ruano; Luciana Meirelles; Leandro L Freitas; Luis A Magna; Ubirajara Ferreira; Athanase Billis
Journal:  Int Urol Nephrol       Date:  2008-06-19       Impact factor: 2.370

8.  Iatrogenic and non-iatrogenic positive margins: incidence, site, factors involved, and time to PSA progression following radical prostatectomy.

Authors:  Athanase Billis; Isabela C Watanabe; Matheus V Costa; Gilliat H Telles; Luis A Magna
Journal:  Int Urol Nephrol       Date:  2007-06-30       Impact factor: 2.370

9.  Higher prostate weight is inversely associated with Gleason score upgrading in radical prostatectomy specimens.

Authors:  Leonardo Oliveira Reis; Emerson Luis Zani; Leandro L L Freitas; Fernandes Denardi; Athanase Billis
Journal:  Adv Urol       Date:  2013-10-31

10.  Predictive criteria of insignificant prostate cancer: what is the correspondence of linear extent to percentage of cancer in a single core?

Authors:  Athanase Billis; Maisa M Q Quintal; Leandro L L Freitas; Larissa B E Costa; Ubirajara Ferreira
Journal:  Int Braz J Urol       Date:  2015 Mar-Apr       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.